Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Emory University
M.D. Anderson Cancer Center
Petrov, Andrey
Ohio State University
M.D. Anderson Cancer Center
Sanford Health
Thomas Jefferson University
Columbia University
Vanderbilt-Ingram Cancer Center
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Osaka University
University of Wisconsin, Madison
Abramson Cancer Center at Penn Medicine
Roswell Park Cancer Institute
University Health Network, Toronto
M.D. Anderson Cancer Center
British Columbia Cancer Agency
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Oklahoma